Abstract:Importance: Research is beginning to elucidate the sophisticated mechanisms underlying the microbiota-gut-brain-immune interface, moving from primarily animal models to human studies. Findings support the dynamic relationships between the gut microbiota as an ecosystem (microbiome) within an ecosystem (host) and its intersection with the host immune and nervous systems. Adding this to the effects on epigenetic regulation of gene expression further complicates and strengthens the response. At the heart is inflammation, which manifests in a variety of pathologies including neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Multiple Sclerosis (MS). Observations: Generally, the research to date is limited and has focused on bacteria, likely due to the simplicity and cost-effectiveness of 16s rRNA sequencing, despite its lower resolution and inability to determine functional ability/alterations. However, this omits all other microbiota including fungi, viruses, and phages, which are emerging as key members of the human microbiome. Much of the research has been done in pre-clinical models and/or in small human studies in more developed parts of the world. The relationships observed are promising but cannot be considered reliable or generalizable at this time. Specifically, causal relationships cannot be determined currently. More research has been done in Alzheimer's disease, followed by Parkinson's disease, and then little in MS. The data for MS is encouraging despite this. Conclusions and relevance: While the research is still nascent, the microbiota-gut-brain-immune interface may be a missing link, which has hampered our progress on understanding, let alone preventing, managing, or putting into remission neurodegenerative diseases. Relationships must first be established in humans, as animal models have been shown to poorly translate to complex human physiology and environments, especially when investigating the human gut microbiome and its relationships where animal models are often overly simplistic. Only then can robust research be conducted in humans and using mechanistic model systems.

Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons-A Comprehensive Review

Physiologically informed neuromodulation

Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression

A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments

Frontiers and future perspectives of neuroimmunology

Neuroimmune interactions and their roles in neurodegenerative diseases

Frontiers of Neurodegenerative Disease Treatment: Targeting Immune Cells in Brain Border Regions

Navigating the nano-bio immune interface: advancements and challenges in CNS nanotherapeutics

Recent Advances in Nanotherapeutics for Neurological Disorders

Neuroimmune interactions: From bench to bedside

Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies

Neuromicrobiology Comes of Age: The Multifaceted Interactions between the Microbiome and the Nervous System

Navigating the blurred path of mixed neuro-immune signaling

Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders

Innovative Avenue to Combat Neurodegenerative Diseases

Neuromodulation by the immune system: a focus on cytokines

Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders

Thinking Outside the Brain for Cognitive Improvement: is Peripheral Immunomodulation on the Way?

The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature

Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders

Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions